First cancer patient has new metabolic imaging technique in UK trialBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2044 (Published 11 April 2016) Cite this as: BMJ 2016;353:i2044
- Susan Mayor
A patient with cancer has become the first in Europe to undergo scanning with a new metabolic imaging technique, in a UK trial designed to assess whether it can rapidly detect a drug treatment’s effectiveness at killing cancer cells.
The imaging technique uses hyperpolarised pyruvate, a breakdown product of glucose that is labelled with non-radioactive carbon-13 ([1-13C] pyruvate), to characterise alterations in tumour metabolism non-invasively. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial